B Ganguly,U Das,A K Das
B Ganguly
Canine transmissible venereal tumour (CTVT) is a contagious venereal tumour of dogs, commonly observed in dogs that are in close contact with one another, or in stray and wild dogs that exhibit unrestrained sexual activity. CTVT represents ...
Detection of comorbidities and synchronous primary tumours via thoracic radiography and abdominal ultrasonography and their influence on treatment outcome in dogs with soft tissue sarcomas, primary brain tumours and intranasal tumours [0.03%]
胸部放射和腹部超声检测软组织肉瘤、原发脑肿瘤和鼻腔肿瘤伴发疾病的状况及对治疗结果的影响
A Bigio Marcello,T L Gieger,D A Jiménez et al.
A Bigio Marcello et al.
Canine soft tissue sarcomas (STS), primary brain tumours and intranasal tumours are commonly treated with radiotherapy (RT). Given the low metastatic potential of these tumours, recommendations regarding imaging tests as staging are variabl...
Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs [0.03%]
Mechlorethamine，vincristine，melphalan和prednisone (MOMP)治疗复发性淋巴瘤的狗
A R Back,S E Schleis,O A Smrkovski et al.
A R Back et al.
Eighty-eight dogs with relapsed lymphoma were treated with the MOMP (mechlorethamine, vincristine, melphalan and prednisone) protocol on a 28-day treatment cycle. The overall response rate (ORR) to the MOMP protocol was 51.1% for a median o...
A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma [0.03%]
Oncept疫苗辅助治疗犬口腔恶性黑色素瘤的疗效回顾性分析
J M Ottnod,R C Smedley,R Walshaw et al.
J M Ottnod et al.
Oral malignant melanoma (OMM) in the dog is often locally aggressive with a high metastatic potential and there are few treatment options that have been demonstrated to improve outcome of this disease. The purpose of this study was to deter...
David M Vail
David M Vail
Effects of low-dose cyclophosphamide with piroxicam on tumour neovascularization in a canine oral malignant melanoma-xenografted mouse model [0.03%]
低剂量环磷酰胺与吡咯昔康对犬口腔恶性黑色素瘤异种移植小鼠模型肿瘤新生血管化的影响
N Choisunirachon,T Jaroensong,K Yoshida et al.
N Choisunirachon et al.
Low-dose cyclophosphamide (CyLD) has shown promise in the treatment of several cancers; however, the effect of CyLD on canine oral malignant melanoma has never been explored. In this study, we investigated the effects of CyLD with or withou...
Three-dimensional conformal radiation therapy alone or in combination with surgery for treatment of canine intracranial meningiomas [0.03%]
单独或联合手术使用三维适形放射治疗犬脑膜瘤
M A Keyerleber,M C McEntee,J Farrelly et al.
M A Keyerleber et al.
Treatment protocols, treatment planning methods and tumour types in studies evaluating radiotherapy for canine brain tumours have been varied. This case series retrospectively evaluated the outcome of definitive, three-dimensional conformal...
Comparative Study
Veterinary and comparative oncology. 2015 Dec;13(4):385-97. DOI:10.1111/vco.12054 2015
Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease [0.03%]
血清胸苷激酶1和C反应蛋白作为筛查临床健康犬隐性疾病生物标志物的研究
K A Selting,C R Sharp,R Ringold et al.
K A Selting et al.
Thymidine kinase (TK1) is a biomarker that correlates well with diagnosis and prognosis in certain canine cancers. Canine C-reactive protein (cCRP) is a widely accepted marker of inflammation correlated with increased risk and severity of v...
Masitinib mesylate for metastatic and non-resectable canine cutaneous mast cell tumours [0.03%]
曲马替尼治疗转移性和不可手术的犬皮肤肥大细胞瘤
O A Smrkovski,L Essick,B W Rohrbach et al.
O A Smrkovski et al.
Masitinib mesylate is a tyrosine kinase inhibitor approved for the treatment of gross, non-metastatic grade II and III canine mast cell tumours (MCTs). This study evaluated the use of masitinib as a frontline and rescue agent for metastatic...
Determination of MDR1 gene expression for prediction of chemotherapy tolerance and treatment outcome in dogs with lymphoma [0.03%]
多药耐药基因表达量检测预测淋巴瘤化疗效果和预后的研究
I Gramer,M Kessler,J Geyer
I Gramer
The multidrug resistance gene 1(MDR1) expression levels were analysed in 27 dogs with different types of malignant lymphomas receiving a standard chemotherapy protocol. Blood samples were used for MDR1 real-time PCR expression analysis. Tre...